Found: 72
Select item for more details and to access through your institution.
Type XX Collagen Is Elevated in Circulation of Patients with Solid Tumors.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 8, p. 4144, doi. 10.3390/ijms23084144
- By:
- Publication type:
- Article
Serum YKL-40 and gestational diabetes - an observational cohort study.
- Published in:
- APMIS, 2016, v. 124, n. 9, p. 770, doi. 10.1111/apm.12573
- By:
- Publication type:
- Article
Identification of proteins secreted by human osteoblastic cells in culture.
- Published in:
- Journal of Bone & Mineral Research, 1992, v. 7, n. 5, p. 501, doi. 10.1002/jbmr.5650070506
- By:
- Publication type:
- Article
Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.
- Published in:
- BMC Pulmonary Medicine, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2466-13-77
- By:
- Publication type:
- Article
Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers.
- Published in:
- Biomarker Research, 2017, v. 5, p. 1, doi. 10.1186/s40364-017-0087-6
- By:
- Publication type:
- Article
Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109430
- By:
- Publication type:
- Article
miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3<sup>rd</sup> Line Cetuximab and Irinotecan.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0099886
- By:
- Publication type:
- Article
Antibody Directed against Human YKL-40 Increases Tumor Volume in a Human Melanoma Xenograft Model in Scid Mice.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095822
- By:
- Publication type:
- Article
Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087746
- By:
- Publication type:
- Article
Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067059
- By:
- Publication type:
- Article
CD6 and Syntaxin Binding Protein 6 Variants and Response to Tumor Necrosis Factor Alpha Inhibitors in Danish Patients with Rheumatoid Arthritis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038539
- By:
- Publication type:
- Article
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1485, doi. 10.1007/s00262-007-0293-4
- By:
- Publication type:
- Article
The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 19, p. 5603, doi. 10.3390/jcm11195603
- By:
- Publication type:
- Article
Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 9, p. 1315, doi. 10.3390/biom12091315
- By:
- Publication type:
- Article
The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults.
- Published in:
- Clinical Endocrinology, 1991, v. 35, n. 6, p. 471, doi. 10.1111/j.1365-2265.1991.tb00930.x
- By:
- Publication type:
- Article
Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1062, doi. 10.3390/cancers15041062
- By:
- Publication type:
- Article
Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 897, doi. 10.3390/cancers15030897
- By:
- Publication type:
- Article
Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133250
- By:
- Publication type:
- Article
Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4599, doi. 10.3390/cancers13184599
- By:
- Publication type:
- Article
YKL-40--A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?
- Published in:
- Cancers, 2010, v. 2, n. 3, p. 1453, doi. 10.3390/cancers2031453
- By:
- Publication type:
- Article
Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11470-5
- By:
- Publication type:
- Article
The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease.
- Published in:
- Inflammation Research, 2011, v. 60, n. 3, p. 281, doi. 10.1007/s00011-010-0266-5
- By:
- Publication type:
- Article
Plasma YKL-40 is elevated in patients with recurrent atrial fibrillation after catheter ablation.
- Published in:
- Inflammation Research, 2010, v. 59, n. 6, p. 463, doi. 10.1007/s00011-009-0146-z
- By:
- Publication type:
- Article
Combined plasma C‐reactive protein, interleukin 6 and YKL‐40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6675, doi. 10.1002/cam4.5455
- By:
- Publication type:
- Article
Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 3972, doi. 10.1002/cam4.5240
- By:
- Publication type:
- Article
Blood‐based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 5, p. 1036, doi. 10.1002/ijc.34356
- By:
- Publication type:
- Article
CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients.
- Published in:
- Arthritis Research & Therapy, 2014, v. 16, n. 5, p. 1, doi. 10.1186/s13075-014-0475-3
- By:
- Publication type:
- Article
High serum YKL-40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 4, p. 310, doi. 10.1111/j.1600-0609.2007.01027.x
- By:
- Publication type:
- Article
Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.
- Published in:
- European Journal of Haematology, 2006, v. 77, n. 5, p. 416, doi. 10.1111/j.0902-4441.2006.t01-1-EJH2879.x
- By:
- Publication type:
- Article
Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases.
- Published in:
- PLoS ONE, 2020, v. 15, n. 8, p. 1, doi. 10.1371/journal.pone.0236569
- By:
- Publication type:
- Article
Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.
- Published in:
- Cancer Science, 2005, v. 96, n. 3, p. 183, doi. 10.1111/j.1349-7006.2005.00026.x
- By:
- Publication type:
- Article
YKL-40 and Alcoholic Liver and Pancreas Damage and Disease in 86258 Individuals from the General Population: Cohort and Mendelian Randomization Studies.
- Published in:
- Clinical Chemistry, 2014, v. 60, n. 11, p. 1429, doi. 10.1373/clinchem.2014.229096
- By:
- Publication type:
- Article
Plasma YKL-40 and Total and Disease-Specific Mortality in the General Population.
- Published in:
- Clinical Chemistry, 2010, v. 56, n. 10, p. 1580, doi. 10.1373/clinchem.2010.146530
- By:
- Publication type:
- Article
The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure.
- Published in:
- Rheumatology, 2013, v. 52, n. 7, p. 1245, doi. 10.1093/rheumatology/ket017
- By:
- Publication type:
- Article
Serum YKL-40 and bone marrow angiogenesis in multiple myeloma.
- Published in:
- International Journal of Cancer, 2009, v. 124, n. 6, p. 1492, doi. 10.1002/ijc.24110
- By:
- Publication type:
- Article
High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
- Published in:
- International Journal of Cancer, 2008, v. 122, n. 4, p. 857, doi. 10.1002/ijc.23152
- By:
- Publication type:
- Article
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Elevated plasma YKL-40 levels and ischemic stroke in the general population.
- Published in:
- Annals of Neurology, 2010, v. 68, n. 5, p. 672, doi. 10.1002/ana.22220
- By:
- Publication type:
- Article
Prognostic value of PINP, bone alkaline phosphatase, CTX‐I, and YKL‐40 in patients with metastatic prostate carcinomaPart of the results has previously been presented at the ASCO meeting in Chicago 2003, abstract number 1525.
- Published in:
- Prostate, 2006, v. 66, n. 5, p. 503, doi. 10.1002/pros.20311
- By:
- Publication type:
- Article
Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87130-0
- By:
- Publication type:
- Article
Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-020-79608-0
- By:
- Publication type:
- Article
Plasma YKL-40 in Inuit and Danes.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Plasma YKL-40 in Inuit and Danes.
- Published in:
- Alcohol & Alcoholism, 2015, v. 50, n. 1, p. 11
- By:
- Publication type:
- Article
Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha‐1 chain (PRO‐C11) in patients with pancreatic ductal adenocarcinoma.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 1, p. 228, doi. 10.1002/ijc.33551
- By:
- Publication type:
- Article